https://els-solutions.com/mercado-de-robotica-medica-devera-atingir-us-246-bilhoes-ate-2025/ 2023-07-11T18:27:39+00:00 https://els-solutions.com/cms/wp-content/uploads/2023/07/els-solutions-robotics-news-pharma.png https://els-solutions.com/aprovados-novos-medicamentos-e-dispositivos-medicos/ 2023-08-10T13:25:25+00:00 https://els-solutions.com/cms/wp-content/uploads/2023/07/els-solutions-medicines-news-pharma.png https://els-solutions.com/principais-5-inovacoes-tecnologicas-na-odontologia-em-2023/ 2023-08-10T13:38:41+00:00 https://els-solutions.com/cms/wp-content/uploads/2023/07/els-solutions-dental-news-pharma.jpg https://els-solutions.com/projeto-de-lei-preve-o-cultivo-de-cannabis-para-fins-medicinais/ 2023-08-10T13:44:13+00:00 https://els-solutions.com/cms/wp-content/uploads/2023/07/els-solutions-marijuana-news-pharma.jpg https://els-solutions.com/ciencia-regulatoria-avancada-na-uniao-europeia/ 2023-08-10T13:52:24+00:00 https://els-solutions.com/cms/wp-content/uploads/2023/07/els-solutions-technology-news-pharma.png https://els-solutions.com/atualizacao-composicao-vacinas-covid-19-novas-variantes/ 2023-08-10T14:00:58+00:00 https://els-solutions.com/cms/wp-content/uploads/2023/07/els-solutions-vaccine-news-pharma.jpg https://els-solutions.com/anvisa-suspende-produtos-de-empresa-de-suplementos-alimentares/ 2023-08-10T14:07:47+00:00 https://els-solutions.com/cms/wp-content/uploads/2023/07/els-solutions-supplement-news-pharma.png https://els-solutions.com/a-notificacao-previa-de-transacoes-de-medicamentos-para-o-exterior-foi-atualizada/ 2023-08-10T14:14:48+00:00 https://els-solutions.com/cms/wp-content/uploads/2023/07/els-solutions-medicine-news-pharma.jpg https://els-solutions.com/a-nossa-equipa-esteve-presente-na-naturaltech-em-sao-paulo/ 2023-08-10T14:21:13+00:00 https://els-solutions.com/cms/wp-content/uploads/2023/08/ELS-Solutions-Naturaltech-Fair-Natural-Products.png https://els-solutions.com/conselho-de-comercio-e-tecnologia-produtos-veterinarios/ 2023-08-10T14:26:07+00:00 https://els-solutions.com/cms/wp-content/uploads/2023/08/ELS-Solutions-Veterinary-Products-EU-US.png https://els-solutions.com/medicamento-tratamento-hiv-autorizado-relatorio-quinzenal-extensao-terapeutica/ 2023-08-10T14:31:04+00:00 https://els-solutions.com/cms/wp-content/uploads/2023/08/ELS-Solutions-HIV-Treatment-therapeutic-extension.jpg https://els-solutions.com/comercio-bilateral-produtos-saude-brasil/ 2023-08-10T14:39:47+00:00 https://els-solutions.com/cms/wp-content/uploads/2023/08/ELS-Solutions-Malaysians-intensify-bilateral-trade-health-products-Brazil.png https://els-solutions.com/novas-regras-para-rotulagem-de-medicamentos-no-brasil/ 2023-08-10T14:45:07+00:00 https://els-solutions.com/cms/wp-content/uploads/2023/08/ELS-Solutions-New-rules-drug-labeling-Brazil.png https://els-solutions.com/fisa-team-food-sector/ 2023-08-14T11:42:11+00:00 https://els-solutions.com/cms/wp-content/uploads/2023/08/ELS-Solutions-FISA-Team-Food-Sector.png https://els-solutions.com/en/fisa-team-food-sector/ 2023-08-24T11:02:16+00:00 https://els-solutions.com/cms/wp-content/uploads/2023/08/ELS-Solutions-FISA-Team-Food-Sector.png https://els-solutions.com/en/els-team-was-present-at-naturaltech-in-saopaulo/ 2023-08-24T11:49:42+00:00 https://els-solutions.com/cms/wp-content/uploads/2023/08/ELS-Solutions-Naturaltech-Fair-Natural-Products.png https://els-solutions.com/en/advancing-regulatory-science-in-the-eu/ 2023-08-24T12:00:49+00:00 https://els-solutions.com/cms/wp-content/uploads/2023/07/els-solutions-technology-news-pharma.png https://els-solutions.com/pt-pt/fisa-team-food-sector/ 2023-08-24T12:18:51+00:00 https://els-solutions.com/cms/wp-content/uploads/2023/08/ELS-Solutions-FISA-Team-Food-Sector.png https://els-solutions.com/cofepris-deteta-sete-novos-distribuidores-irregulares-de-medicamentos/ 2023-08-28T09:55:54+00:00 https://els-solutions.com/cms/wp-content/uploads/2023/08/ELS-Solutions-Cofrepris-Mexico-Irregular-Medicine-Distributors.png https://els-solutions.com/els-solutions-alerta-surto-de-antibioticos-nas-infeccoes-respiratorias-do-inverno/ 2023-08-28T10:18:22+00:00 https://els-solutions.com/cms/wp-content/uploads/2023/08/ELS-Solutions-Warning-Atibiotic-Breakout-Winter-Respiratory-Infections.png https://els-solutions.com/infarmed-aprovou-novo-medicamento-contra-diversos-cancros/ 2023-08-28T10:30:08+00:00 https://els-solutions.com/cms/wp-content/uploads/2023/08/ELS-Solutions-Infarmed-Innovative-Medicine-Cancer.png https://els-solutions.com/a-sindusfarma-apela-novo-quadro-rotulagem-medicamentos/ 2023-08-30T17:06:10+00:00 https://els-solutions.com/cms/wp-content/uploads/2023/08/ELS-Solutions-Sindusfarma-New-Medicines-Labeling-1.jpg https://els-solutions.com/cofepris-autoriza-nova-vacina-contra-gripe-idosos/ 2023-08-30T17:10:26+00:00 https://els-solutions.com/cms/wp-content/uploads/2023/08/ELS-Solutions-Cofepris-New-Vaccine-Seniors.png https://els-solutions.com/anvisa-alerta-sobre-produtos-esteticos-usados-na-forma-injetavel/ 2023-10-16T15:41:03+00:00 https://els-solutions.com/cms/wp-content/uploads/2023/10/ELS-Solutions-Anvisa-Aesthetic-Products-Injection.png https://els-solutions.com/rdc-635-alteracoes-no-transporte-e-armazenamento-de-medicamentos/ 2023-10-23T14:52:44+00:00 https://els-solutions.com/cms/wp-content/uploads/2023/10/ELS-Solutions-RDC653-Changes-Storage-Transportation-Medicines.png https://els-solutions.com/pt-pt/anvisa-alteracoes-rdc-821-2023-in-258-2023/ 2023-11-21T00:06:57+00:00 https://els-solutions.com/cms/wp-content/uploads/2023/11/els-solutions-anvisa-pharmaceutical-impurities-products-documentation-1.jpg https://els-solutions.com/anvisa-alteracoes-rdc-821-2023-in-258-2023/ 2023-11-21T00:06:57+00:00 https://els-solutions.com/cms/wp-content/uploads/2023/11/els-solutions-anvisa-pharmaceutical-impurities-products-documentation-1.jpg https://els-solutions.com/cofepris-regulacao-seguranca-dispositivos-medicos/ 2023-11-21T00:20:52+00:00 https://els-solutions.com/cms/wp-content/uploads/2023/11/ELS-Solutions-Cofepris-Regulatory-Safety-Medical-Devices-1.jpg https://els-solutions.com/pt-pt/anvisa-regula-a-importacao-dispositivos-medicos/ 2023-11-21T00:43:25+00:00 https://els-solutions.com/cms/wp-content/uploads/2023/11/Anvisa-Import-Medical-Devices-1.jpg https://els-solutions.com/anvisa-regula-a-importacao-dispositivos-medicos/ 2023-11-21T00:43:25+00:00 https://els-solutions.com/cms/wp-content/uploads/2023/11/Anvisa-Import-Medical-Devices-1.jpg https://els-solutions.com/anvisa-medidas-contra-uso-inadequado-cosmeticos-injetaveis/ 2023-11-21T01:39:17+00:00 https://els-solutions.com/cms/wp-content/uploads/2023/11/Anvisa-Cosmetic-Injectables-1.jpg https://els-solutions.com/anvisa-atualiza-aprovacao-importacao-pre-embarque/ 2023-11-21T01:52:16+00:00 https://els-solutions.com/cms/wp-content/uploads/2023/11/Anvisa-Import-Pre-Shipment-1.jpg https://els-solutions.com/pt-pt/fda-propoe-revogar-autorizacao-do-uso-bvo-em-alimentos/ 2023-11-21T02:21:31+00:00 https://els-solutions.com/cms/wp-content/uploads/2023/11/FDA-Regulations-BVO-Food-1.jpg https://els-solutions.com/fda-propoe-revogar-autorizacao-do-uso-bvo-em-alimentos/ 2023-11-21T02:21:31+00:00 https://els-solutions.com/cms/wp-content/uploads/2023/11/FDA-Regulations-BVO-Food-1.jpg https://els-solutions.com/pt-pt/anvisa-atualiza-aprovacao-importacao-pre-embarque/ 2023-11-21T02:23:44+00:00 https://els-solutions.com/cms/wp-content/uploads/2023/11/Anvisa-Import-Pre-Shipment-1.jpg https://els-solutions.com/anvisa-atualiza-pedido-formulario-para-importacao/ 2023-12-15T11:15:09+00:00 https://els-solutions.com/cms/wp-content/uploads/2023/12/ELS-Solutions-Anvisa-updates-application-form-1.jpg https://els-solutions.com/pt-pt/anvisa-atualiza-pedido-formulario-para-importacao/ 2023-12-15T11:15:09+00:00 https://els-solutions.com/cms/wp-content/uploads/2023/12/ELS-Solutions-Anvisa-updates-application-form-1.jpg https://els-solutions.com/mapa-apreende-9-000-garrafas-de-azeite-fraudulento-no-parana/ 2023-12-15T11:31:15+00:00 https://els-solutions.com/cms/wp-content/uploads/2023/12/ELS-Solutions-Mapa-seizes-fraudulent-olive-1.jpg https://els-solutions.com/anvisa-apoia-desenvolvimento-de-novos-dispositivos-medicos/ 2023-12-15T11:35:15+00:00 https://els-solutions.com/cms/wp-content/uploads/2023/12/ELS-Solutions-New-call-for-proposals-1.jpg https://els-solutions.com/pt-pt/anvisa-apoia-desenvolvimento-de-novos-dispositivos-medicos/ 2023-12-15T11:35:15+00:00 https://els-solutions.com/cms/wp-content/uploads/2023/12/ELS-Solutions-New-call-for-proposals-1.jpg https://els-solutions.com/mapa-apreende-azeite-falsificado-e-feijao-com-impurezas/ 2023-12-15T11:40:20+00:00 https://els-solutions.com/cms/wp-content/uploads/2023/12/ELS-Solutions-Mapa-seizes-oil-beans-1.jpg https://els-solutions.com/en/anvisa-update-request-form-for-importation/ 2023-12-15T11:49:07+00:00 https://els-solutions.com/cms/wp-content/uploads/2023/12/ELS-Solutions-Anvisa-updates-application-form-1.jpg https://els-solutions.com/pt-pt/anvisa-alerta-sobre-produtos-esteticos-usados-na-forma-injetavel/ 2023-12-19T18:14:40+00:00 https://els-solutions.com/cms/wp-content/uploads/2023/10/ELS-Solutions-Anvisa-Aesthetic-Products-Injection.png https://els-solutions.com/pt-pt/rdc-635-alteracoes-no-transporte-e-armazenamento-de-medicamentos/ 2023-12-19T18:33:18+00:00 https://els-solutions.com/cms/wp-content/uploads/2023/10/ELS-Solutions-RDC653-Changes-Storage-Transportation-Medicines.png https://els-solutions.com/pt-pt/anvisa-medidas-contra-uso-inadequado-cosmeticos-injetaveis/ 2023-12-19T18:34:58+00:00 https://els-solutions.com/cms/wp-content/uploads/2023/11/Anvisa-Cosmetic-Injectables-1.jpg https://els-solutions.com/en/anvisa-alert-on-aesthetic-products-used-in-injectable-forms/ 2023-12-19T18:36:19+00:00 https://els-solutions.com/cms/wp-content/uploads/2023/10/ELS-Solutions-Anvisa-Aesthetic-Products-Injection.png https://els-solutions.com/en/anvisa-new-measures-ban-cosmetics-injectable-form/ 2023-12-19T18:37:32+00:00 https://els-solutions.com/cms/wp-content/uploads/2023/11/Anvisa-Cosmetic-Injectables.jpg https://els-solutions.com/en/fda-proposes-repeal-regulations-use-bvo-food/ 2023-12-19T18:44:29+00:00 https://els-solutions.com/cms/wp-content/uploads/2023/11/FDA-Regulations-BVO-Food.jpg https://els-solutions.com/en/cofepris-new-regulatory-safety-strategy-for-medical-devices/ 2023-12-19T18:47:13+00:00 https://els-solutions.com/cms/wp-content/uploads/2023/11/ELS-Solutions-Cofepris-Regulatory-Safety-Medical-Devices.jpg https://els-solutions.com/en/rdc-635-changes-in-transport-and-storage-of-medicines/ 2023-12-19T18:47:23+00:00 https://els-solutions.com/cms/wp-content/uploads/2023/10/ELS-Solutions-RDC653-Changes-Storage-Transportation-Medicines.png https://els-solutions.com/en/anvisa-rdc-821-2023-and-in-for-qualified-impurities-published/ 2024-01-08T16:49:27+00:00 https://els-solutions.com/cms/wp-content/uploads/2023/11/els-solutions-anvisa-pharmaceutical-impurities-products-documentation.jpg https://els-solutions.com/mapa-inspecciona-o-comercio-de-vinhos-contrabandeados/ 2024-01-08T17:55:24+00:00 https://els-solutions.com/cms/wp-content/uploads/2023/12/ELS-Solutions-Mapa-inspects-trade-1.jpg https://els-solutions.com/viminol-passou-a-ser-uma-substancia-controlada/ 2024-01-08T17:56:59+00:00 https://els-solutions.com/cms/wp-content/uploads/2024/01/ELS-Solutions-Viminol-becomes-a-controlled-substance-1.jpg https://els-solutions.com/cofepris-facilita-acesso-medicamentos-inovadores/ 2024-01-08T17:58:36+00:00 https://els-solutions.com/cms/wp-content/uploads/2024/01/ELS-Solutions-Mexico-will-have-greater-access-to-innovative-medicines-1.jpg https://els-solutions.com/operacao-conjunta-de-combate-as-importacoes-ilegais/ 2024-01-08T18:00:18+00:00 https://els-solutions.com/cms/wp-content/uploads/2023/12/ELS-Solutions-Joint-operation-1.jpg https://els-solutions.com/pt-pt/cofepris-regulacao-seguranca-dispositivos-medicos/ 2024-01-08T18:21:41+00:00 https://els-solutions.com/cms/wp-content/uploads/2023/11/ELS-Solutions-Cofepris-Regulatory-Safety-Medical-Devices-1.jpg https://els-solutions.com/atualizacao-farmacopeia-brasileira/ 2024-01-11T19:13:06+00:00 https://els-solutions.com/cms/wp-content/uploads/2024/01/ELS-Solutions-Update-of-the-Brazilian-Pharmacopoeia-1.jpg https://els-solutions.com/anvisa-permite-uso-reservas-embalagens-rotulos/ 2024-01-11T19:16:22+00:00 https://els-solutions.com/cms/wp-content/uploads/2024/01/ELS-Solutions-deadline-set-for-use-of-old-packaging-1.jpg https://els-solutions.com/anvisa-aprova-tratamento-cancro-avancado-brasil/ 2024-01-11T19:19:06+00:00 https://els-solutions.com/cms/wp-content/uploads/2024/01/ELS-Solutions-new-advanced-cancer-treatment-in-Brazil-1.jpg https://els-solutions.com/brasil-presenca-15-feiras-alimentos-globais-2023/ 2024-01-11T19:22:13+00:00 https://els-solutions.com/cms/wp-content/uploads/2024/01/ELS-Solutions-Brazil-at-15-Global-Food-Fairs-in-2023-1.jpg https://els-solutions.com/anvisa-publica-manual-de-regulamentacao-de-protetores-solares/ 2024-02-16T12:33:35+00:00 https://els-solutions.com/cms/wp-content/uploads/2024/02/ELS-Solutions-Regulation-sunscreans-1-1.jpg https://els-solutions.com/aprovados-medicamentos-e-investigacao-clinica-em-2023/ 2024-02-16T12:35:04+00:00 https://els-solutions.com/cms/wp-content/uploads/2024/02/ELS-Solutions-medices-and-clinical-research-1.jpg https://els-solutions.com/medicamentos-genericos-25-anos/ 2024-02-16T12:36:03+00:00 https://els-solutions.com/cms/wp-content/uploads/2024/02/ELS-Solutions-Generic-drugs-1.jpg https://els-solutions.com/pt-pt/medicamentos-genericos-25-anos/ 2024-02-16T12:36:03+00:00 https://els-solutions.com/cms/wp-content/uploads/2024/02/ELS-Solutions-Generic-drugs-1.jpg https://els-solutions.com/anvisa-publica-nova-edicao-do-manual-de-biovigilancia/ 2024-02-16T12:38:04+00:00 https://els-solutions.com/cms/wp-content/uploads/2024/02/ELS-Solutions-anvisa-published-new-edition-1.jpg https://els-solutions.com/anvisa-aprova-nova-vacina-covid-19/ 2024-02-16T12:38:28+00:00 https://els-solutions.com/cms/wp-content/uploads/2024/02/ELS-Solutions-ANVISA-has-approved-the-registration-of-the-Covid-19-vaccine-1.jpg https://els-solutions.com/relatorios-avaliam-risco-e-beneficio-de-lista-de-medicamentos/ 2024-02-16T12:38:57+00:00 https://els-solutions.com/cms/wp-content/uploads/2024/02/ELS-Solutions-list-of-drugs-for-which-Drug-Registration-Holders-must-submit-Periodic-1.jpg https://els-solutions.com/inicio-da-forca-tarefa-biologica-em-projeto-analise-otimizada/ 2024-02-19T18:07:17+00:00 https://els-solutions.com/cms/wp-content/uploads/2024/02/ELS-Solutions-start-of-biological-task-force-in-project-analysis-optimized-1.jpg https://els-solutions.com/anvisa-publica-relatorio-de-gestao-da-ggmed/ 2024-02-19T18:16:10+00:00 https://els-solutions.com/cms/wp-content/uploads/2024/02/ELS-Solutions-Anvisa-publishes-GGMED-Management-Report-1.jpg https://els-solutions.com/pt-pt/principais-5-inovacoes-tecnologicas-na-odontologia-em-2023/ 2024-02-20T15:19:14+00:00 https://els-solutions.com/cms/wp-content/uploads/2023/07/els-solutions-dental-news-pharma.jpg https://els-solutions.com/pt-pt/mercado-de-robotica-medica-devera-atingir-us-246-bilhoes-ate-2025/ 2024-02-20T15:22:37+00:00 https://els-solutions.com/cms/wp-content/uploads/2023/07/els-solutions-robotics-news-pharma.png https://els-solutions.com/pt-pt/cofepris-deteta-sete-novos-distribuidores-irregulares-de-medicamentos/ 2024-02-20T15:28:52+00:00 https://els-solutions.com/cms/wp-content/uploads/2023/08/ELS-Solutions-Cofrepris-Mexico-Irregular-Medicine-Distributors.png https://els-solutions.com/pt-pt/a-nossa-equipa-esteve-presente-na-naturaltech-em-sao-paulo/ 2024-02-20T15:34:37+00:00 https://els-solutions.com/cms/wp-content/uploads/2023/08/ELS-Solutions-Naturaltech-Fair-Natural-Products.png https://els-solutions.com/pt-pt/anvisa-suspende-produtos-de-empresa-de-suplementos-alimentares/ 2024-02-20T15:40:09+00:00 https://els-solutions.com/cms/wp-content/uploads/2023/07/els-solutions-supplement-news-pharma.png https://els-solutions.com/pt-pt/projeto-de-lei-preve-o-cultivo-de-cannabis-para-fins-medicinais/ 2024-02-20T15:42:56+00:00 https://els-solutions.com/cms/wp-content/uploads/2023/07/els-solutions-marijuana-news-pharma.jpg https://els-solutions.com/pt-pt/a-notificacao-previa-de-transacoes-de-medicamentos-para-o-exterior-foi-atualizada/ 2024-02-20T15:45:21+00:00 https://els-solutions.com/cms/wp-content/uploads/2023/07/els-solutions-medicine-news-pharma.jpg https://els-solutions.com/en/malaysians-want-to-intensify-bilateral-trade-in-health-products-with-brazil/ 2024-02-20T15:48:53+00:00 https://els-solutions.com/cms/wp-content/uploads/2023/08/ELS-Solutions-Malaysians-intensify-bilateral-trade-health-products-Brazil.png https://els-solutions.com/en/cofrepris-mexico-irregular-medicine-distributors/ 2024-02-20T16:03:48+00:00 https://els-solutions.com/cms/wp-content/uploads/2023/08/ELS-Solutions-Cofrepris-Mexico-Irregular-Medicine-Distributors.png https://els-solutions.com/en/top-5-technological-innovations-in-dentistry-in-2023/ 2024-02-20T16:06:46+00:00 https://els-solutions.com/cms/wp-content/uploads/2023/07/els-solutions-dental-news-pharma.jpg https://els-solutions.com/en/new-rules-for-drug-labeling-in-brazil/ 2024-02-20T16:16:01+00:00 https://els-solutions.com/cms/wp-content/uploads/2023/08/ELS-Solutions-New-rules-drug-labeling-Brazil.png https://els-solutions.com/en/sindusfarma-calls-new-regulatory-framework-drug-labeling/ 2024-02-20T16:17:57+00:00 https://els-solutions.com/cms/wp-content/uploads/2023/08/ELS-Solutions-Sindusfarma-New-Medicines-Labeling-1.jpg https://els-solutions.com/en/warnings-to-prevent-antibiotic-breakouts-this-winter/ 2024-02-20T16:19:15+00:00 https://els-solutions.com/cms/wp-content/uploads/2023/08/ELS-Solutions-Warning-Atibiotic-Breakout-Winter-Respiratory-Infections.png https://els-solutions.com/en/infarmed-authorized-innovative-medicine-for-several-types-of-cancer/ 2024-02-20T16:24:08+00:00 https://els-solutions.com/cms/wp-content/uploads/2023/08/ELS-Solutions-Infarmed-Innovative-Medicine-Cancer.png https://els-solutions.com/fda-estreia-diretorio-ingredientes-suplementos-alimentares/ 2024-03-04T16:41:47+00:00 https://els-solutions.com/cms/wp-content/uploads/2024/03/ELS-Solutions-FDA-launches-new-directory-1.jpg https://els-solutions.com/anvisa-atualizara-norma-sobre-tartrazina-em-rotulos/ 2024-03-04T16:46:17+00:00 https://els-solutions.com/cms/wp-content/uploads/2024/03/ELS-Solutions-recording-of-the-sector-dialog-on-the-labeling-of-foods-1.jpg https://els-solutions.com/anvisa-anuncia-selecao-dispositivos-medicos-inovadores/ 2024-03-11T14:35:53+00:00 https://els-solutions.com/cms/wp-content/uploads/2024/03/ELS-Solutions-results-of-selection-of-innovative-medical-devices-1.jpg https://els-solutions.com/anvisa-integra-programa-oea-integracao-completa/ 2024-03-11T14:38:05+00:00 https://els-solutions.com/cms/wp-content/uploads/2024/03/ELS-Solutions-Anvsa-Joins-OAS-1.jpg https://els-solutions.com/pt-pt/anvisa-integra-programa-oea-integracao-completa/ 2024-03-11T14:38:05+00:00 https://els-solutions.com/cms/wp-content/uploads/2024/03/ELS-Solutions-Anvsa-Joins-OAS-1.jpg https://els-solutions.com/anvisa-estabelece-nova-regulacao-inovadora-setor-alimentar/ 2024-03-11T14:39:48+00:00 https://els-solutions.com/cms/wp-content/uploads/2024/03/ELS-Solutions-Anvisa-adopts-new-regulatory-approach-for-the-food-sector-1.jpg https://els-solutions.com/en/anvisa-joins-the-oas-full-integration-program/ 2024-03-11T14:42:59+00:00 https://els-solutions.com/cms/wp-content/uploads/2024/03/ELS-Solutions-Anvsa-Joins-OAS-1.jpg https://els-solutions.com/infarmed-aprova-comercializacao-tres-produtos-cannabis/ 2024-03-19T11:16:04+00:00 https://els-solutions.com/cms/wp-content/uploads/2024/03/ELS-Solutions-lnfarmed-approves-marketing-of-three-cannabis-based-products-1.jpg https://els-solutions.com/anvisa-amplia-prazo-validade-certificado-boas-praticas/ 2024-04-02T12:17:42+00:00 https://els-solutions.com/cms/wp-content/uploads/2024/04/ELS-Solutions-Anvisa-extends-deadline-for-Good-Practice-certificates-1.jpg https://els-solutions.com/anvisa-prioriza-registo-dispositivos-dengue/ 2024-04-09T11:34:02+00:00 https://els-solutions.com/cms/wp-content/uploads/2024/04/ELS-Solutions-Dengue-diagnostic-devices-1.jpg https://els-solutions.com/decreto-lei-executa-regulamento-ue-dispositivos-sobre-medicos/ 2024-04-09T11:37:04+00:00 https://els-solutions.com/cms/wp-content/uploads/2024/04/ELS-Solutions-Implementation-of-the-Medical-Devices-Regulation-1.jpg https://els-solutions.com/en/generic-drugs-25-years/ 2024-04-12T12:00:46+00:00 https://els-solutions.com/cms/wp-content/uploads/2024/02/ELS-Solutions-Generic-drugs-1.jpg https://els-solutions.com/pt-pt/infarmed-aprovou-novo-medicamento-contra-diversos-cancros/ 2024-04-12T12:29:12+00:00 https://els-solutions.com/cms/wp-content/uploads/2023/08/ELS-Solutions-Infarmed-Innovative-Medicine-Cancer.png https://els-solutions.com/pt-pt/cofepris-autoriza-nova-vacina-contra-gripe-idosos/ 2024-04-12T12:31:17+00:00 https://els-solutions.com/cms/wp-content/uploads/2023/08/ELS-Solutions-Cofepris-New-Vaccine-Seniors.png https://els-solutions.com/pt-pt/anvisa-permite-uso-reservas-embalagens-rotulos/ 2024-04-12T18:19:50+00:00 https://els-solutions.com/cms/wp-content/uploads/2024/01/ELS-Solutions-deadline-set-for-use-of-old-packaging-1.jpg https://els-solutions.com/pt-pt/infarmed-aprova-comercializacao-tres-produtos-cannabis/ 2024-04-12T18:21:39+00:00 https://els-solutions.com/cms/wp-content/uploads/2024/03/ELS-Solutions-lnfarmed-approves-marketing-of-three-cannabis-based-products-1.jpg https://els-solutions.com/anvisa-utilizara-analise-externa-para-registrar-dispositivos-medicos/ 2024-04-17T10:00:42+00:00 https://els-solutions.com/cms/wp-content/uploads/2024/04/ELS-Solutions-Anvisa-to-use-external-analysis-to-register-medical-devices-1.jpg https://els-solutions.com/pt-pt/medicamento-tratamento-hiv-autorizado-relatorio-quinzenal-extensao-terapeutica/ 2024-04-22T18:16:22+00:00 https://els-solutions.com/cms/wp-content/uploads/2023/08/ELS-Solutions-HIV-Treatment-therapeutic-extension.jpg https://els-solutions.com/en/trade-and-technology-council-veterinary-products/ 2024-04-22T18:23:21+00:00 https://els-solutions.com/cms/wp-content/uploads/2023/08/ELS-Solutions-Veterinary-Products-EU-US.png https://els-solutions.com/en/ecdc-ema-joint-statement-composition-covid-19-vaccines/ 2024-04-22T18:25:35+00:00 https://els-solutions.com/cms/wp-content/uploads/2023/07/els-solutions-vaccine-news-pharma.jpg https://els-solutions.com/en/transactions-in-medicines-outside-the-country-updated/ 2024-04-22T18:27:17+00:00 https://els-solutions.com/cms/wp-content/uploads/2023/07/els-solutions-medicine-news-pharma.jpg https://els-solutions.com/estado-sp-aprova-protocolo-canabidiol-tetrahidrocanabinol/ 2024-05-15T17:33:59+00:00 https://els-solutions.com/cms/wp-content/uploads/2024/05/ELS-Solutions-cannabis-1.jpg https://els-solutions.com/relatorio-aprovado-revisar-regulamento-bens-importados/ 2024-05-27T14:33:55+00:00 https://els-solutions.com/cms/wp-content/uploads/2024/05/ELS-Solutions-report-device-1.jpg https://els-solutions.com/protocole-licenca-importacao-reclassificacao-ncm/ 2024-05-27T14:39:32+00:00 https://els-solutions.com/cms/wp-content/uploads/2024/05/ELS-Solutions-Import-license-1.jpg https://els-solutions.com/pt-pt/anvisa-atualizara-norma-sobre-tartrazina-em-rotulos/ 2024-06-02T00:58:30+00:00 https://els-solutions.com/cms/wp-content/uploads/2024/03/ELS-Solutions-recording-of-the-sector-dialog-on-the-labeling-of-foods-1.jpg https://els-solutions.com/pt-pt/conselho-de-comercio-e-tecnologia-produtos-veterinarios/ 2024-06-02T00:59:27+00:00 https://els-solutions.com/cms/wp-content/uploads/2023/08/ELS-Solutions-Veterinary-Products-EU-US.png https://els-solutions.com/pt-pt/els-solutions-alerta-surto-de-antibioticos-nas-infeccoes-respiratorias-do-inverno/ 2024-06-02T01:04:02+00:00 https://els-solutions.com/cms/wp-content/uploads/2023/08/ELS-Solutions-Warning-Atibiotic-Breakout-Winter-Respiratory-Infections.png https://els-solutions.com/pt-pt/atualizacao-farmacopeia-brasileira/ 2024-06-02T01:04:58+00:00 https://els-solutions.com/cms/wp-content/uploads/2024/01/ELS-Solutions-Update-of-the-Brazilian-Pharmacopoeia-1.jpg https://els-solutions.com/pt-pt/operacao-conjunta-de-combate-as-importacoes-ilegais/ 2024-06-02T01:05:54+00:00 https://els-solutions.com/cms/wp-content/uploads/2023/12/ELS-Solutions-Joint-operation-1.jpg https://els-solutions.com/pt-pt/atualizacao-composicao-vacinas-covid-19-novas-variantes/ 2024-06-03T01:19:21+00:00 https://els-solutions.com/cms/wp-content/uploads/2023/07/els-solutions-vaccine-news-pharma.jpg https://els-solutions.com/pt-pt/relatorios-avaliam-risco-e-beneficio-de-lista-de-medicamentos/ 2024-06-03T01:23:19+00:00 https://els-solutions.com/cms/wp-content/uploads/2024/02/ELS-Solutions-list-of-drugs-for-which-Drug-Registration-Holders-must-submit-Periodic-1.jpg https://els-solutions.com/pt-pt/aprovados-medicamentos-e-investigacao-clinica-em-2023/ 2024-06-03T01:30:06+00:00 https://els-solutions.com/cms/wp-content/uploads/2024/02/ELS-Solutions-medices-and-clinical-research-1.jpg https://els-solutions.com/pt-pt/cofepris-facilita-acesso-medicamentos-inovadores/ 2024-06-03T01:37:06+00:00 https://els-solutions.com/cms/wp-content/uploads/2024/01/ELS-Solutions-Mexico-will-have-greater-access-to-innovative-medicines-1.jpg https://els-solutions.com/pt-pt/anvisa-publica-relatorio-de-gestao-da-ggmed/ 2024-06-03T01:40:59+00:00 https://els-solutions.com/cms/wp-content/uploads/2024/02/ELS-Solutions-Anvisa-publishes-GGMED-Management-Report-1.jpg https://els-solutions.com/pt-pt/mapa-inspecciona-o-comercio-de-vinhos-contrabandeados/ 2024-06-03T01:43:03+00:00 https://els-solutions.com/cms/wp-content/uploads/2023/12/ELS-Solutions-Mapa-inspects-trade-1.jpg https://els-solutions.com/pt-pt/ciencia-regulatoria-avancada-na-uniao-europeia/ 2024-06-03T01:46:51+00:00 https://els-solutions.com/cms/wp-content/uploads/2023/07/els-solutions-technology-news-pharma.png https://els-solutions.com/pt-pt/novas-regras-para-rotulagem-de-medicamentos-no-brasil/ 2024-06-03T01:48:30+00:00 https://els-solutions.com/cms/wp-content/uploads/2023/08/ELS-Solutions-New-rules-drug-labeling-Brazil.png https://els-solutions.com/pt-pt/aprovados-novos-medicamentos-e-dispositivos-medicos/ 2024-06-03T08:25:21+00:00 https://els-solutions.com/cms/wp-content/uploads/2023/07/els-solutions-medicines-news-pharma.png https://els-solutions.com/pt-pt/anvisa-publica-nova-edicao-do-manual-de-biovigilancia/ 2024-06-03T08:26:33+00:00 https://els-solutions.com/cms/wp-content/uploads/2024/02/ELS-Solutions-anvisa-published-new-edition-1.jpg https://els-solutions.com/pt-pt/viminol-passou-a-ser-uma-substancia-controlada/ 2024-06-03T08:27:38+00:00 https://els-solutions.com/cms/wp-content/uploads/2024/01/ELS-Solutions-Viminol-becomes-a-controlled-substance-1.jpg https://els-solutions.com/pt-pt/comercio-bilateral-produtos-saude-brasil/ 2024-06-03T08:28:58+00:00 https://els-solutions.com/cms/wp-content/uploads/2023/08/ELS-Solutions-Malaysians-intensify-bilateral-trade-health-products-Brazil.png https://els-solutions.com/pt-pt/anvisa-aprova-tratamento-cancro-avancado-brasil/ 2024-06-03T08:30:24+00:00 https://els-solutions.com/cms/wp-content/uploads/2024/01/ELS-Solutions-new-advanced-cancer-treatment-in-Brazil-1.jpg https://els-solutions.com/pt-pt/anvisa-anuncia-selecao-dispositivos-medicos-inovadores/ 2024-06-03T08:34:04+00:00 https://els-solutions.com/cms/wp-content/uploads/2024/03/ELS-Solutions-results-of-selection-of-innovative-medical-devices-1.jpg https://els-solutions.com/pt-pt/a-sindusfarma-apela-novo-quadro-rotulagem-medicamentos/ 2024-06-03T08:35:20+00:00 https://els-solutions.com/cms/wp-content/uploads/2023/08/ELS-Solutions-Sindusfarma-New-Medicines-Labeling-1.jpg https://els-solutions.com/pt-pt/anvisa-aprova-nova-vacina-covid-19/ 2024-06-03T08:36:31+00:00 https://els-solutions.com/cms/wp-content/uploads/2024/02/ELS-Solutions-ANVISA-has-approved-the-registration-of-the-Covid-19-vaccine-1.jpg https://els-solutions.com/en/viminol-has-become-a-controlled-substance/ 2024-06-03T10:07:27+00:00 https://els-solutions.com/cms/wp-content/uploads/2024/01/ELS-Solutions-Viminol-becomes-a-controlled-substance-1.jpg https://els-solutions.com/en/anvisa-publishes-ggmed-management-report/ 2024-06-03T10:39:57+00:00 https://els-solutions.com/cms/wp-content/uploads/2024/02/ELS-Solutions-Anvisa-publishes-GGMED-Management-Report-1.jpg https://els-solutions.com/en/drug-hiv-treatment-authorized-biweekly-therapeutic-report/ 2024-06-03T10:42:23+00:00 https://els-solutions.com/cms/wp-content/uploads/2023/08/ELS-Solutions-HIV-Treatment-therapeutic-extension.jpg https://els-solutions.com/en/cofepris-authorizes-new-influenza-vaccine-for-seniors/ 2024-06-03T10:45:05+00:00 https://els-solutions.com/cms/wp-content/uploads/2023/08/ELS-Solutions-Cofepris-New-Vaccine-Seniors.png https://els-solutions.com/en/infarmed-approves-commercialization-of-cannabis-products/ 2024-06-03T10:48:59+00:00 https://els-solutions.com/cms/wp-content/uploads/2024/03/ELS-Solutions-lnfarmed-approves-marketing-of-three-cannabis-based-products-1.jpg https://els-solutions.com/en/21-new-drugs-151-medical-devices-and-seven-clinical-trials-were-approved/ 2024-06-03T10:51:20+00:00 https://els-solutions.com/cms/wp-content/uploads/2023/07/els-solutions-medicines-news-pharma.png https://els-solutions.com/en/update-brazilian-pharmacopoeia/ 2024-06-03T10:53:17+00:00 https://els-solutions.com/cms/wp-content/uploads/2024/01/ELS-Solutions-Update-of-the-Brazilian-Pharmacopoeia-1.jpg https://els-solutions.com/en/cofepris-facilitates-access-to-innovative-medicines/ 2024-06-03T10:55:13+00:00 https://els-solutions.com/cms/wp-content/uploads/2024/01/ELS-Solutions-Mexico-will-have-greater-access-to-innovative-medicines-1.jpg https://els-solutions.com/en/anvisa-to-support-the-development-of-new-medical-devices/ 2024-06-03T10:56:19+00:00 https://els-solutions.com/cms/wp-content/uploads/2023/12/ELS-Solutions-New-call-for-proposals-1.jpg https://els-solutions.com/en/anvisa-publica-manual-de-regulamentacao-de-protectores-solares/ 2024-06-03T10:57:20+00:00 https://els-solutions.com/cms/wp-content/uploads/2024/02/ELS-Solutions-Regulation-sunscreans-1-1.jpg https://els-solutions.com/en/anvisa-regulates-import-regularized-medical-devices/ 2024-06-03T10:58:53+00:00 https://els-solutions.com/cms/wp-content/uploads/2023/11/Anvisa-Import-Medical-Devices.jpg https://els-solutions.com/en/approved-medicines-and-clinical-research-in-2023/ 2024-06-03T11:01:54+00:00 https://els-solutions.com/cms/wp-content/uploads/2024/02/ELS-Solutions-medices-and-clinical-research-1.jpg https://els-solutions.com/en/anvisa-announces-selection-of-innovative-medical-devices/ 2024-06-03T11:02:59+00:00 https://els-solutions.com/cms/wp-content/uploads/2024/03/ELS-Solutions-results-of-selection-of-innovative-medical-devices-1.jpg https://els-solutions.com/en/anvisa-approves-new-covid-19-vaccine/ 2024-06-03T11:04:23+00:00 https://els-solutions.com/cms/wp-content/uploads/2024/02/ELS-Solutions-ANVISA-has-approved-the-registration-of-the-Covid-19-vaccine-1.jpg https://els-solutions.com/en/anvisa-publishes-new-edition-of-the-biosurveillance-manual/ 2024-06-03T11:05:37+00:00 https://els-solutions.com/cms/wp-content/uploads/2024/02/ELS-Solutions-anvisa-published-new-edition-1.jpg https://els-solutions.com/en/joint-operation-to-combat-illegal-imports/ 2024-06-03T11:06:42+00:00 https://els-solutions.com/cms/wp-content/uploads/2023/12/ELS-Solutions-Joint-operation-1.jpg https://els-solutions.com/en/anvisa-update-rule-on-tartrazine-in-labels/ 2024-06-03T11:07:44+00:00 https://els-solutions.com/cms/wp-content/uploads/2024/03/ELS-Solutions-recording-of-the-sector-dialog-on-the-labeling-of-foods-1.jpg https://els-solutions.com/en/mapa-inspects-the-smuggled-wine-trade/ 2024-06-03T11:13:17+00:00 https://els-solutions.com/cms/wp-content/uploads/2023/12/ELS-Solutions-Mapa-inspects-trade-1.jpg https://els-solutions.com/en/anvisa-suspends-products-from-food-supplement-company/ 2024-06-03T11:14:16+00:00 https://els-solutions.com/cms/wp-content/uploads/2023/07/els-solutions-supplement-news-pharma.png https://els-solutions.com/en/fda-premiere-directorate-ingredients-food-supplements/ 2024-06-03T11:15:27+00:00 https://els-solutions.com/cms/wp-content/uploads/2024/03/ELS-Solutions-FDA-launches-new-directory-1.jpg https://els-solutions.com/en/anvisa-allows-reserves-packaging-labels/ 2024-06-03T11:16:53+00:00 https://els-solutions.com/cms/wp-content/uploads/2024/01/ELS-Solutions-deadline-set-for-use-of-old-packaging-1.jpg https://els-solutions.com/en/reports-evaluate-risk-and-benefit-of-drug-lists/ 2024-06-03T13:59:10+00:00 https://els-solutions.com/cms/wp-content/uploads/2024/02/ELS-Solutions-list-of-drugs-for-which-Drug-Registration-Holders-must-submit-Periodic-1.jpg https://els-solutions.com/en/medical-robotics-market-to-reach-24-billion-by-2025/ 2024-06-03T14:00:58+00:00 https://els-solutions.com/cms/wp-content/uploads/2023/07/els-solutions-robotics-news-pharma.png https://els-solutions.com/en/project-of-law-foresees-the-cultivation-of-marijuana-for-medicinal-purposes/ 2024-06-03T14:02:56+00:00 https://els-solutions.com/cms/wp-content/uploads/2023/07/els-solutions-marijuana-news-pharma.jpg https://els-solutions.com/en/brazil-presence-15-fairs-global-foods-2023/ 2024-06-03T14:04:34+00:00 https://els-solutions.com/cms/wp-content/uploads/2024/01/ELS-Solutions-Brazil-at-15-Global-Food-Fairs-in-2023-1.jpg https://els-solutions.com/anvisa-aprova-regulamento-para-biossimilares/ 2024-06-06T15:49:46+00:00 https://els-solutions.com/cms/wp-content/uploads/2024/06/ELS-Solutions-Anvisa-approves-registering-biosimilar-medicines-1.jpg https://els-solutions.com/pt-pt/anvisa-aprova-regulamento-para-biossimilares/ 2024-06-06T15:49:46+00:00 https://els-solutions.com/cms/wp-content/uploads/2024/06/ELS-Solutions-Anvisa-approves-registering-biosimilar-medicines-1.jpg https://els-solutions.com/aprovada-analise-impacto-regulatorio-cannabis/ 2024-06-06T15:51:49+00:00 https://els-solutions.com/cms/wp-content/uploads/2024/06/ELS-Solutions-cannabis-regulatory-report-aproved-1.jpg https://els-solutions.com/pt-pt/aprovada-analise-impacto-regulatorio-cannabis/ 2024-06-06T15:51:49+00:00 https://els-solutions.com/cms/wp-content/uploads/2024/06/ELS-Solutions-cannabis-regulatory-report-aproved-1.jpg https://els-solutions.com/en/anvisa-approves-regulations-for-biosimilars/ 2024-06-06T15:54:00+00:00 https://els-solutions.com/cms/wp-content/uploads/2024/06/ELS-Solutions-Anvisa-approves-registering-biosimilar-medicines-1.jpg https://els-solutions.com/en/regulatory-impact-analysis-cannabis-approved/ 2024-06-06T15:55:12+00:00 https://els-solutions.com/cms/wp-content/uploads/2024/06/ELS-Solutions-cannabis-regulatory-report-aproved-1.jpg https://els-solutions.com/anvisa-suspende-transferencia-titularidade-temporariamente/ 2024-06-14T13:51:33+00:00 https://els-solutions.com/cms/wp-content/uploads/2024/06/ELS-Solutions-anvisa-transfer-ownership-suspension-1.jpg https://els-solutions.com/pt-pt/anvisa-suspende-transferencia-titularidade-temporariamente/ 2024-06-14T16:38:28+00:00 https://els-solutions.com/cms/wp-content/uploads/2024/06/ELS-Solutions-anvisa-transfer-ownership-suspension-1.jpg https://els-solutions.com/en/anvisa-suspends-transfer-of-ownership-temporarily/ 2024-06-14T16:39:39+00:00 https://els-solutions.com/cms/wp-content/uploads/2024/06/ELS-Solutions-anvisa-transfer-ownership-suspension-1.jpg https://els-solutions.com/anvisa-proibe-fenol-tratamentos-medicos-esteticos/ 2024-07-05T12:35:08+00:00 https://els-solutions.com/cms/wp-content/uploads/2024/07/ELS-Solutions-Anvisa-bans-the-use-of-phenol-1.jpg https://els-solutions.com/pt-pt/anvisa-proibe-fenol-tratamentos-medicos-esteticos/ 2024-07-05T12:35:08+00:00 https://els-solutions.com/cms/wp-content/uploads/2024/07/ELS-Solutions-Anvisa-bans-the-use-of-phenol-1.jpg https://els-solutions.com/enquadrar-reenquadrar-regulamentacao-medicamentos/ 2024-07-05T12:37:51+00:00 https://els-solutions.com/cms/wp-content/uploads/2024/07/ELS-Solutions-medicines-regulation-1.jpg https://els-solutions.com/pt-pt/enquadrar-reenquadrar-regulamentacao-medicamentos/ 2024-07-05T12:37:51+00:00 https://els-solutions.com/cms/wp-content/uploads/2024/07/ELS-Solutions-medicines-regulation-1.jpg https://els-solutions.com/en/framing-reframing-regulation-medicines/ 2024-07-05T12:44:05+00:00 https://els-solutions.com/cms/wp-content/uploads/2024/07/ELS-Solutions-medicines-regulation-1.jpg https://els-solutions.com/en/anvisa-bans-phenol-medical-aesthetic-treatments/ 2024-07-05T12:46:13+00:00 https://els-solutions.com/cms/wp-content/uploads/2024/07/ELS-Solutions-Anvisa-bans-the-use-of-phenol-1.jpg https://els-solutions.com/en/anvisa-announces-new-procedure-medicines/ 2024-07-18T15:01:28+00:00 https://els-solutions.com/cms/wp-content/uploads/2024/07/ELS-Solutions-Anvisa-publishes-new-procedure-1.jpg https://els-solutions.com/en/ema-recommends-10-new-drugs/ 2024-07-18T15:02:13+00:00 https://els-solutions.com/cms/wp-content/uploads/2024/07/ELS-Solutions-Meeting-highlights-from-the-Committee-1.jpg https://els-solutions.com/anvisa-divulga-novo-procedimento-medicamentos/ 2024-07-18T15:02:54+00:00 https://els-solutions.com/cms/wp-content/uploads/2024/07/ELS-Solutions-Anvisa-publishes-new-procedure-1.jpg https://els-solutions.com/pt-pt/anvisa-divulga-novo-procedimento-medicamentos/ 2024-07-18T15:02:54+00:00 https://els-solutions.com/cms/wp-content/uploads/2024/07/ELS-Solutions-Anvisa-publishes-new-procedure-1.jpg https://els-solutions.com/lista-medicamentos-exportacao-suspensa-atualizada/ 2024-07-18T15:03:20+00:00 https://els-solutions.com/cms/wp-content/uploads/2024/07/ELS-Solutions-Updating-list-of-medicines-1.jpg https://els-solutions.com/pt-pt/lista-medicamentos-exportacao-suspensa-atualizada/ 2024-07-18T15:03:20+00:00 https://els-solutions.com/cms/wp-content/uploads/2024/07/ELS-Solutions-Updating-list-of-medicines-1.jpg https://els-solutions.com/ema-propoe-aprovacao-dez-novos-medicamentos/ 2024-07-18T15:03:43+00:00 https://els-solutions.com/cms/wp-content/uploads/2024/07/ELS-Solutions-Meeting-highlights-from-the-Committee-1.jpg https://els-solutions.com/pt-pt/ema-propoe-aprovacao-dez-novos-medicamentos/ 2024-07-18T15:03:43+00:00 https://els-solutions.com/cms/wp-content/uploads/2024/07/ELS-Solutions-Meeting-highlights-from-the-Committee-1.jpg https://els-solutions.com/en/nasal-medication-anaphylactic-reactions/ 2024-07-23T09:24:37+00:00 https://els-solutions.com/cms/wp-content/uploads/2024/07/ELS-Solutions-First-drug-for-nasal-administration-1.jpg https://els-solutions.com/en/infarmed-approves-new-acm-cannabis-preparations/ 2024-07-23T09:26:17+00:00 https://els-solutions.com/cms/wp-content/uploads/2024/07/ELS-Solutions-INFARMED-approved-medicinal-canabis-1.jpg https://els-solutions.com/medicamento-nasal-reacoes-anafilaticas/ 2024-07-23T09:27:40+00:00 https://els-solutions.com/cms/wp-content/uploads/2024/07/ELS-Solutions-First-drug-for-nasal-administration-1.jpg https://els-solutions.com/infarmed-aprova-novos-acm-preparacoes-de-cannabis/ 2024-07-23T09:28:51+00:00 https://els-solutions.com/cms/wp-content/uploads/2024/07/ELS-Solutions-INFARMED-approved-medicinal-canabis-1.jpg https://els-solutions.com/pt-pt/infarmed-aprova-novos-acm-preparacoes-de-cannabis/ 2024-07-23T09:28:51+00:00 https://els-solutions.com/cms/wp-content/uploads/2024/07/ELS-Solutions-INFARMED-approved-medicinal-canabis-1.jpg https://els-solutions.com/ue-divulga-consensus-statement-dispositivos-medicos/ 2024-08-02T11:44:21+00:00 https://els-solutions.com/cms/wp-content/uploads/2024/07/ELS-Solutions-approved-consensus-statement-1.jpg https://els-solutions.com/aemps-medicamentos-alergenicos/ 2024-08-02T11:48:51+00:00 https://els-solutions.com/cms/wp-content/uploads/2024/07/ELS-Solutions-list-of-allergen-based-1.jpg https://els-solutions.com/pt-pt/aemps-medicamentos-alergenicos/ 2024-08-02T11:48:51+00:00 https://els-solutions.com/cms/wp-content/uploads/2024/07/ELS-Solutions-list-of-allergen-based-1.jpg https://els-solutions.com/atualizam-meios-pedido-inspecao-gmp-aim-italia/ 2024-08-02T11:51:27+00:00 https://els-solutions.com/cms/wp-content/uploads/2024/08/ELS-Solutions-Updating-the-means-of-requesting-1.jpg https://els-solutions.com/alteram-rotulos-produtos-cosmeticos-portugal/ 2024-08-02T11:55:10+00:00 https://els-solutions.com/cms/wp-content/uploads/2024/08/ELS-Solutions-new-components-to-the-list-1.jpg https://els-solutions.com/pt-pt/alteram-rotulos-produtos-cosmeticos-portugal/ 2024-08-02T11:55:10+00:00 https://els-solutions.com/cms/wp-content/uploads/2024/08/ELS-Solutions-new-components-to-the-list-1.jpg https://els-solutions.com/reconhecem-inspecao-medicamentos-espanha/ 2024-08-02T11:57:34+00:00 https://els-solutions.com/cms/wp-content/uploads/2024/08/ELS-Solutions-Inspections-AEMPS-1.jpg https://els-solutions.com/pt-pt/reconhecem-inspecao-medicamentos-espanha/ 2024-08-02T11:57:34+00:00 https://els-solutions.com/cms/wp-content/uploads/2024/08/ELS-Solutions-Inspections-AEMPS-1.jpg https://els-solutions.com/en/eu-releases-consensus-statement-medical-devices/ 2024-08-02T11:59:57+00:00 https://els-solutions.com/cms/wp-content/uploads/2024/07/ELS-Solutions-approved-consensus-statement-1.jpg https://els-solutions.com/en/aemps-releases-resolution-allergenic-medicines/ 2024-08-02T12:02:43+00:00 https://els-solutions.com/cms/wp-content/uploads/2024/07/ELS-Solutions-list-of-allergen-based-1.jpg https://els-solutions.com/en/gmp-aim-inspection-application-forms-italy-updated/ 2024-08-02T12:04:57+00:00 https://els-solutions.com/cms/wp-content/uploads/2024/08/ELS-Solutions-Updating-the-means-of-requesting-1-1.jpg https://els-solutions.com/en/cosmetic-product-labels-change-portugal/ 2024-08-02T12:06:31+00:00 https://els-solutions.com/cms/wp-content/uploads/2024/08/ELS-Solutions-new-components-to-the-list-1.jpg https://els-solutions.com/infarmed-atualiza-precos-grupos-homogeneos/ 2024-08-28T12:47:53+00:00 https://els-solutions.com/cms/wp-content/uploads/2024/08/ELS-Solutions-reference-price-system-1.jpg https://els-solutions.com/pt-pt/infarmed-atualiza-precos-grupos-homogeneos/ 2024-08-28T12:47:53+00:00 https://els-solutions.com/cms/wp-content/uploads/2024/08/ELS-Solutions-reference-price-system-1.jpg https://els-solutions.com/infarmed-atualiza-medicamentos-exportacao/ 2024-08-28T12:49:30+00:00 https://els-solutions.com/cms/wp-content/uploads/2024/08/ELS-Solutions-updating-export-controlled-medicines-1.jpg https://els-solutions.com/pt-pt/infarmed-atualiza-medicamentos-exportacao/ 2024-08-28T12:49:30+00:00 https://els-solutions.com/cms/wp-content/uploads/2024/08/ELS-Solutions-updating-export-controlled-medicines-1.jpg https://els-solutions.com/comissao-europeia-avalia-diretiva-medicamentos-falsificados/ 2024-08-28T12:51:31+00:00 https://els-solutions.com/cms/wp-content/uploads/2024/08/ELS-Solutions-falsified-medicines-directive-1.jpg https://els-solutions.com/en/european-committee-evaluates-directive-on-falsified-medicines/ 2024-08-28T12:54:20+00:00 https://els-solutions.com/cms/wp-content/uploads/2024/08/ELS-Solutions-falsified-medicines-directive-1.jpg https://els-solutions.com/en/infarmed-updates-prices-homogeneous-groups/ 2024-08-28T12:56:03+00:00 https://els-solutions.com/cms/wp-content/uploads/2024/08/ELS-Solutions-reference-price-system-1.jpg https://els-solutions.com/en/infarmed-updates-medicines-export/ 2024-08-28T12:58:09+00:00 https://els-solutions.com/cms/wp-content/uploads/2024/08/ELS-Solutions-updating-export-controlled-medicines-1.jpg https://els-solutions.com/pt-pt/dgav-esclarece-usar-biocidas-setor-alimentar/ 2024-09-10T15:03:25+00:00 https://els-solutions.com/cms/wp-content/uploads/2024/09/ELS-Solutions-clarification-food-sector-1.jpg https://els-solutions.com/dgav-esclarece-usar-biocidas-setor-alimentar/ 2024-09-10T15:03:25+00:00 https://els-solutions.com/cms/wp-content/uploads/2024/09/ELS-Solutions-clarification-food-sector-1.jpg https://els-solutions.com/anvisa-simplifica-registo-importacao-vacinas-mpox/ 2024-09-10T15:05:41+00:00 https://els-solutions.com/cms/wp-content/uploads/2024/09/ELS-Solutions-Anvisa-Simplify-registration-vacines-1.jpg https://els-solutions.com/atualizam-lista-medicamentos-exportacao-suspensa/ 2024-09-10T15:08:01+00:00 https://els-solutions.com/cms/wp-content/uploads/2024/09/ELS-Solutions-updating-medicines-supended-1.jpg https://els-solutions.com/en/dgav-clears-using-biocides-food-sector/ 2024-09-10T15:09:37+00:00 https://els-solutions.com/cms/wp-content/uploads/2024/09/ELS-Solutions-clarification-food-sector-1.jpg https://els-solutions.com/en/update-drug-list-export-suspended/ 2024-09-10T15:14:56+00:00 https://els-solutions.com/cms/wp-content/uploads/2024/09/ELS-Solutions-updating-medicines-supended-1.jpg https://els-solutions.com/pt-pt/brasil-presenca-15-feiras-alimentos-globais-2023/ 2024-09-17T17:19:25+00:00 https://els-solutions.com/cms/wp-content/uploads/2024/01/ELS-Solutions-Brazil-at-15-Global-Food-Fairs-in-2023-1.jpg https://els-solutions.com/pt-pt/anvisa-publica-manual-de-regulamentacao-de-protetores-solares/ 2024-09-17T17:20:26+00:00 https://els-solutions.com/cms/wp-content/uploads/2024/02/ELS-Solutions-Regulation-sunscreans-1-1.jpg https://els-solutions.com/pt-pt/fda-estreia-diretorio-ingredientes-suplementos-alimentares/ 2024-09-17T17:22:02+00:00 https://els-solutions.com/cms/wp-content/uploads/2024/03/ELS-Solutions-FDA-launches-new-directory-1.jpg https://els-solutions.com/pt-pt/decreto-lei-executa-regulamento-ue-dispositivos-sobre-medicos/ 2024-09-17T17:24:16+00:00 https://els-solutions.com/cms/wp-content/uploads/2024/04/ELS-Solutions-Implementation-of-the-Medical-Devices-Regulation-1.jpg https://els-solutions.com/pt-pt/mapa-apreende-9-000-garrafas-de-azeite-fraudulento-no-parana/ 2024-09-17T17:30:26+00:00 https://els-solutions.com/cms/wp-content/uploads/2023/12/ELS-Solutions-Mapa-seizes-fraudulent-olive-1.jpg https://els-solutions.com/pt-pt/comissao-europeia-avalia-diretiva-medicamentos-falsificados/ 2024-09-17T17:39:51+00:00 https://els-solutions.com/cms/wp-content/uploads/2024/08/ELS-Solutions-falsified-medicines-directive-1.jpg https://els-solutions.com/pt-pt/inicio-da-forca-tarefa-biologica-em-projeto-analise-otimizada/ 2024-09-17T17:41:15+00:00 https://els-solutions.com/cms/wp-content/uploads/2024/02/ELS-Solutions-start-of-biological-task-force-in-project-analysis-optimized-1.jpg https://els-solutions.com/pt-pt/medicamento-nasal-reacoes-anafilaticas/ 2024-09-17T17:42:53+00:00 https://els-solutions.com/cms/wp-content/uploads/2024/07/ELS-Solutions-First-drug-for-nasal-administration-1.jpg https://els-solutions.com/pt-pt/protocole-licenca-importacao-reclassificacao-ncm/ 2024-09-17T17:45:47+00:00 https://els-solutions.com/cms/wp-content/uploads/2024/05/ELS-Solutions-Import-license-1.jpg https://els-solutions.com/pt-pt/anvisa-amplia-prazo-validade-certificado-boas-praticas/ 2024-09-17T17:47:26+00:00 https://els-solutions.com/cms/wp-content/uploads/2024/04/ELS-Solutions-Anvisa-extends-deadline-for-Good-Practice-certificates-1.jpg https://els-solutions.com/pt-pt/relatorio-aprovado-revisar-regulamento-bens-importados/ 2024-09-17T17:49:04+00:00 https://els-solutions.com/cms/wp-content/uploads/2024/05/ELS-Solutions-report-device-1.jpg https://els-solutions.com/pt-pt/anvisa-utilizara-analise-externa-para-registrar-dispositivos-medicos/ 2024-09-17T17:51:51+00:00 https://els-solutions.com/cms/wp-content/uploads/2024/04/ELS-Solutions-Anvisa-to-use-external-analysis-to-register-medical-devices-1.jpg https://els-solutions.com/pt-pt/mapa-apreende-azeite-falsificado-e-feijao-com-impurezas/ 2024-09-17T17:53:22+00:00 https://els-solutions.com/cms/wp-content/uploads/2023/12/ELS-Solutions-Mapa-seizes-oil-beans-1.jpg https://els-solutions.com/pt-pt/estado-sp-aprova-protocolo-canabidiol-tetrahidrocanabinol/ 2024-09-17T18:04:04+00:00 https://els-solutions.com/cms/wp-content/uploads/2024/05/ELS-Solutions-cannabis-1.jpg https://els-solutions.com/pt-pt/atualizam-meios-pedido-inspecao-gmp-aim-italia/ 2024-09-17T18:05:36+00:00 https://els-solutions.com/cms/wp-content/uploads/2024/08/ELS-Solutions-Updating-the-means-of-requesting-1.jpg https://els-solutions.com/pt-pt/anvisa-prioriza-registo-dispositivos-dengue/ 2024-09-18T17:55:33+00:00 https://els-solutions.com/cms/wp-content/uploads/2024/04/ELS-Solutions-Dengue-diagnostic-devices-1.jpg https://els-solutions.com/en/anvisa-to-use-external-analysis-to-register-medical-devices/ 2024-09-18T17:56:45+00:00 https://els-solutions.com/cms/wp-content/uploads/2024/04/ELS-Solutions-Anvisa-to-use-external-analysis-to-register-medical-devices-1-1.jpg https://els-solutions.com/en/report-approved-revise-regulations-imported-goods/ 2024-09-18T17:58:20+00:00 https://els-solutions.com/cms/wp-content/uploads/2024/05/ELS-Solutions-report-device-1.jpg https://els-solutions.com/en/decree-law-implements-eu-regulation-on-medical-devices/ 2024-09-18T18:29:13+00:00 https://els-solutions.com/cms/wp-content/uploads/2024/04/ELS-Solutions-Implementation-of-the-Medical-Devices-Regulation-1-1.jpg https://els-solutions.com/en/protocole-import-license-after-ncm-reclassification/ 2024-09-18T18:33:58+00:00 https://els-solutions.com/cms/wp-content/uploads/2024/05/ELS-Solutions-Import-license-1-2.jpg https://els-solutions.com/en/anvisa-prioritizes-registration-of-dengue-devices/ 2024-09-18T18:47:28+00:00 https://els-solutions.com/cms/wp-content/uploads/2024/04/ELS-Solutions-Dengue-diagnostic-devices-1-1.jpg https://els-solutions.com/pt-pt/anvisa-estabelece-nova-regulacao-inovadora-setor-alimentar/ 2024-09-18T18:54:14+00:00 https://els-solutions.com/cms/wp-content/uploads/2024/03/ELS-Solutions-Anvisa-adopts-new-regulatory-approach-for-the-food-sector-1.jpg https://els-solutions.com/en/anvisa-updates-import-approval-pre-shipment-requirement/ 2024-09-18T19:28:04+00:00 https://els-solutions.com/cms/wp-content/uploads/2023/11/Anvisa-Import-Pre-Shipment.jpg https://els-solutions.com/en/anvisa-extends-validity-period-good-practices-certificate/ 2024-09-18T19:29:52+00:00 https://els-solutions.com/cms/wp-content/uploads/2024/04/ELS-Solutions-Anvisa-extends-deadline-for-Good-Practice-certificates-1.jpg https://els-solutions.com/en/anvisa-simplifies-import-registration-mpox-vaccines/ 2024-09-18T19:31:11+00:00 https://els-solutions.com/cms/wp-content/uploads/2024/09/ELS-Solutions-Anvisa-Simplify-registration-vacines-1.jpg https://els-solutions.com/en/mapa-seizes-counterfeit-olive-oil-and-beans-with-impurities/ 2024-09-18T19:33:57+00:00 https://els-solutions.com/cms/wp-content/uploads/2023/12/ELS-Solutions-Mapa-seizes-oil-beans-1.jpg https://els-solutions.com/en/sp-state-approves-cannabidiol-tetrahydrocannabinol-protocol/ 2024-09-18T19:35:30+00:00 https://els-solutions.com/cms/wp-content/uploads/2024/05/ELS-Solutions-cannabis-1.jpg https://els-solutions.com/en/anvisa-approves-advanced-cancer-treatment-brazil/ 2024-09-18T20:04:08+00:00 https://els-solutions.com/cms/wp-content/uploads/2024/01/ELS-Solutions-new-advanced-cancer-treatment-in-Brazil-1.jpg https://els-solutions.com/en/start-of-biological-task-force-in-project-analysis-optimized/ 2024-09-18T20:06:46+00:00 https://els-solutions.com/cms/wp-content/uploads/2024/02/ELS-Solutions-start-of-biological-task-force-in-project-analysis-optimized-1.jpg https://els-solutions.com/en/anvisa-establishes-new-regulation-innovative-food-sector/ 2024-09-18T20:10:21+00:00 https://els-solutions.com/cms/wp-content/uploads/2024/03/ELS-Solutions-Anvisa-adopts-new-regulatory-approach-for-the-food-sector-1.jpg https://els-solutions.com/en/map-seizes-9000-bottles-of-fraudulent-oil-in-parana/ 2024-09-18T20:11:30+00:00 https://els-solutions.com/cms/wp-content/uploads/2023/12/ELS-Solutions-Mapa-seizes-fraudulent-olive-1.jpg https://els-solutions.com/en/list-medicines-suspended-exports-has-been-updated/ 2024-09-18T20:15:08+00:00 https://els-solutions.com/cms/wp-content/uploads/2024/07/ELS-Solutions-Updating-list-of-medicines-1.jpg https://els-solutions.com/en/recognize-inspection-medicines-spain/ 2024-09-18T20:16:47+00:00 https://els-solutions.com/cms/wp-content/uploads/2024/08/ELS-Solutions-Inspections-AEMPS-1.jpg https://els-solutions.com/pt-pt/atualizam-lista-medicamentos-exportacao-suspensa/ 2024-09-27T11:47:19+00:00 https://els-solutions.com/cms/wp-content/uploads/2024/09/ELS-Solutions-updating-medicines-supended-1.jpg https://els-solutions.com/pt-pt/anvisa-simplifica-registo-importacao-vacinas-mpox/ 2024-09-27T11:52:55+00:00 https://els-solutions.com/cms/wp-content/uploads/2024/09/ELS-Solutions-Anvisa-Simplify-registration-vacines-1.jpg https://els-solutions.com/importacao-produtos-derivados-cannabis/ 2024-10-09T18:09:49+00:00 https://els-solutions.com/cms/wp-content/uploads/2024/10/Imagem-Noticias-Website-1.png https://els-solutions.com/en/importing-cannabis-derived-products/ 2024-10-09T18:14:52+00:00 https://els-solutions.com/cms/wp-content/uploads/2024/10/Imagem-Noticias-Website.png https://els-solutions.com/pt-pt/importacao-produtos-derivados-cannabis/ 2024-10-09T18:23:00+00:00 https://els-solutions.com/cms/wp-content/uploads/2024/10/Imagem-Noticias-Website-1.png https://els-solutions.com/anvisa-paineis-cadifa/ 2024-11-27T00:18:21+00:00 https://els-solutions.com/cms/wp-content/uploads/2024/11/Anvisa-Cadifa.png https://els-solutions.com/pt-pt/anvisa-paineis-cadifa/ 2024-11-27T00:18:21+00:00 https://els-solutions.com/cms/wp-content/uploads/2024/11/Anvisa-Cadifa.png https://els-solutions.com/en/anvisa-panels-active-pharmaceutical-ingredient-dossier-adequacy-letter/ 2024-11-27T00:28:14+00:00 https://els-solutions.com/cms/wp-content/uploads/2024/11/Anvisa-Cadifa-1.png https://els-solutions.com/avanco-pesquisa-clinica-brasil-anvisa/ 2024-12-04T00:21:33+00:00 https://els-solutions.com/cms/wp-content/uploads/2024/12/Anvisa-Pesquisa-clinica.png https://els-solutions.com/pt-pt/avanco-pesquisa-clinica-brasil-anvisa/ 2024-12-04T00:21:33+00:00 https://els-solutions.com/cms/wp-content/uploads/2024/12/Anvisa-Pesquisa-clinica.png https://els-solutions.com/en/progress-clinical-research-brazil-anvisa/ 2024-12-04T00:27:43+00:00 https://els-solutions.com/cms/wp-content/uploads/2024/12/Anvisa-Pesquisa-clinica-1.png https://els-solutions.com/ema-lanca-consulta-publica-sobre-o-uso-de-dados/ 2024-12-17T17:18:41+00:00 https://els-solutions.com/cms/wp-content/uploads/2024/12/EMA-1.png https://els-solutions.com/pt-pt/ema-lanca-consulta-publica-sobre-o-uso-de-dados/ 2024-12-17T17:28:39+00:00 https://els-solutions.com/cms/wp-content/uploads/2024/12/EMA-1.png https://els-solutions.com/en/ema-launches-a-public-consultation-on-the-use-of-real-world-data-in-the-regulation-of-medicines/ 2024-12-18T14:24:11+00:00 https://els-solutions.com/cms/wp-content/uploads/2024/12/EMA-1.png https://els-solutions.com/portugal-e-o-segundo-maior-exportador-de-canabis-medicinal/ 2024-12-18T17:40:39+00:00 https://els-solutions.com/cms/wp-content/uploads/2024/12/jeff-w-YBBivUN5VRM-unsplash-1.jpg https://els-solutions.com/anvisa-atualiza-procedimentos-para-produtos-fronteira/ 2025-01-07T10:54:07+00:00 https://els-solutions.com/cms/wp-content/uploads/2024/12/anvisa-produtos-fronteira.png https://els-solutions.com/en/anvisa-updates-procedures-for-approval-of-borderline-products/ 2025-01-07T10:54:44+00:00 https://els-solutions.com/cms/wp-content/uploads/2024/12/anvisa-produtos-fronteira.png https://els-solutions.com/pt-pt/anvisa-atualiza-procedimentos-para-produtos-fronteira/ 2025-01-07T15:08:26+00:00 https://els-solutions.com/cms/wp-content/uploads/2024/12/anvisa-produtos-fronteira.png https://els-solutions.com/pt-pt/fda-emitiu-orientacoes-para-submissoes-de-medicamentos-com-ia/ 2025-01-14T15:30:08+00:00 https://els-solutions.com/cms/wp-content/uploads/2025/01/zhenyu-luo-kE0JmtbvXxM-unsplash-1-2-scaled.jpg https://els-solutions.com/fda-emitiu-orientacoes-para-submissoes-de-medicamentos-com-ia/ 2025-01-14T15:30:08+00:00 https://els-solutions.com/cms/wp-content/uploads/2025/01/zhenyu-luo-kE0JmtbvXxM-unsplash-1-2-scaled.jpg https://els-solutions.com/en/fda-proposes-draft-guidance-to-ensure-ai-credibility-in-drug-and-biologic-submissions/ 2025-01-14T16:21:37+00:00 https://els-solutions.com/cms/wp-content/uploads/2025/01/zhenyu-luo-kE0JmtbvXxM-unsplash-1-2-scaled.jpg https://els-solutions.com/en/fda-issues-preliminary-guidance-for-medical-devices-with-artificial-intelligence/ 2025-01-14T17:04:03+00:00 https://els-solutions.com/cms/wp-content/uploads/2025/01/ct-scan-images-computers-arrangement-1-scaled.jpg https://els-solutions.com/en/eu-regulation-2021-2282-on-health-technology-assessment-enters-into-force/ 2025-01-20T13:20:50+00:00 https://els-solutions.com/cms/wp-content/uploads/2025/01/christian-lue-C241mbgtgys-unsplash-2-scaled.jpg https://els-solutions.com/pt-pt/regulamento-2021-2282-de-avaliacao-de-tecnologias-de-saude-da-uniao-europeia-entra-em-vigor/ 2025-01-20T13:20:50+00:00 https://els-solutions.com/cms/wp-content/uploads/2025/01/christian-lue-C241mbgtgys-unsplash-2-scaled.jpg https://els-solutions.com/regulamento-2021-2282-de-avaliacao-de-tecnologias-de-saude-da-uniao-europeia-entra-em-vigor/ 2025-01-20T13:20:50+00:00 https://els-solutions.com/cms/wp-content/uploads/2025/01/christian-lue-C241mbgtgys-unsplash-2-scaled.jpg https://els-solutions.com/fda-emite-orientacao-preliminar-para-dispositivos-medicos-com-inteligencia-artificial/ 2025-01-20T13:54:30+00:00 https://els-solutions.com/cms/wp-content/uploads/2025/01/ct-scan-images-computers-arrangement-1-scaled.jpg https://els-solutions.com/en/fda-issues-preliminary-guidance-for-medical-devices-with-artificial-intelligence-2/ 2025-01-20T13:56:41+00:00 https://els-solutions.com/cms/wp-content/uploads/2025/01/ct-scan-images-computers-arrangement-1-scaled.jpg https://els-solutions.com/pt-pt/fda-emite-orientacao-preliminar-para-dispositivos-medicos-com-inteligencia-artificial/ 2025-01-20T13:57:13+00:00 https://els-solutions.com/cms/wp-content/uploads/2025/01/ct-scan-images-computers-arrangement-1-scaled.jpg https://els-solutions.com/pt-pt/ue-divulga-consensus-statement-dispositivos-medicos/ 2025-01-20T15:58:04+00:00 https://els-solutions.com/cms/wp-content/uploads/2024/07/ELS-Solutions-approved-consensus-statement-1.jpg https://els-solutions.com/anvisa-faz-mudancas-no-registro-de-medicamentos/ 2025-01-25T20:29:23+00:00 https://els-solutions.com/cms/wp-content/uploads/2025/01/pills-pills-pills-3-1326912-1-scaled.jpg https://els-solutions.com/pt-pt/anvisa-faz-mudancas-no-registro-de-medicamentos/ 2025-01-25T20:37:10+00:00 https://els-solutions.com/cms/wp-content/uploads/2025/01/pills-pills-pills-3-1326912-1-scaled.jpg https://els-solutions.com/en/portugal-is-the-second-largest-exporter-of-medicinal-cannabis/ 2025-01-25T20:49:47+00:00 https://els-solutions.com/cms/wp-content/uploads/2024/12/jeff-w-YBBivUN5VRM-unsplash-1.jpg https://els-solutions.com/pt-pt/portugal-e-o-segundo-maior-exportador-de-canabis-medicinal/ 2025-01-25T20:51:45+00:00 https://els-solutions.com/cms/wp-content/uploads/2024/12/jeff-w-YBBivUN5VRM-unsplash-1.jpg https://els-solutions.com/en/public-consultation-on-eu-medical-device-regulations/ 2025-02-03T10:50:18+00:00 https://els-solutions.com/cms/wp-content/uploads/2025/02/high-angle-surgical-instruments-arrangement-1-scaled.jpg https://els-solutions.com/pt-pt/consulta-publica-sobre-regulamentos-de-dispositivos-medicos/ 2025-02-03T10:50:18+00:00 https://els-solutions.com/cms/wp-content/uploads/2025/02/high-angle-surgical-instruments-arrangement-1-scaled.jpg https://els-solutions.com/consulta-publica-sobre-regulamentos-de-dispositivos-medicos/ 2025-02-03T10:50:18+00:00 https://els-solutions.com/cms/wp-content/uploads/2025/02/high-angle-surgical-instruments-arrangement-1-scaled.jpg https://els-solutions.com/en/apmc-conducts-innovative-study-on-medicinal-cannabis/ 2025-02-03T16:56:10+00:00 https://els-solutions.com/cms/wp-content/uploads/2025/02/doctor-hand-hold-offer-patient-medical-marijuana-oil-1-2-scaled.jpg https://els-solutions.com/apmc-conduz-estudo-inovador-sobre-cannabis-medicinal/ 2025-02-03T16:56:10+00:00 https://els-solutions.com/cms/wp-content/uploads/2025/02/doctor-hand-hold-offer-patient-medical-marijuana-oil-1-2-scaled.jpg https://els-solutions.com/pt-pt/apmc-conduz-estudo-inovador-sobre-cannabis-medicinal/ 2025-02-03T16:57:47+00:00 https://els-solutions.com/cms/wp-content/uploads/2025/02/doctor-hand-hold-offer-patient-medical-marijuana-oil-1-2-scaled.jpg https://els-solutions.com/fda-propoe-nova-etiqueta-nutricional/ 2025-02-03T17:25:07+00:00 https://els-solutions.com/cms/wp-content/uploads/2025/02/medium-shot-woman-writing-1-scaled.jpg https://els-solutions.com/pt-pt/fda-propoe-nova-etiqueta-nutricional/ 2025-02-03T17:25:27+00:00 https://els-solutions.com/cms/wp-content/uploads/2025/02/medium-shot-woman-writing-1-scaled.jpg https://els-solutions.com/en/fda-proposes-new-nutrition-label-for-healthier-choices/ 2025-02-03T17:25:58+00:00 https://els-solutions.com/cms/wp-content/uploads/2025/02/medium-shot-woman-writing-1-scaled.jpg https://els-solutions.com/anvisa-atualiza-procedimentos-para-enquadramento-de-produtos-fronteira-mais-eficiencia-e-acesso-a-inovacoes-no-setor-de-saude/ 2025-02-05T23:47:06+00:00 https://els-solutions.com/cms/wp-content/uploads/2025/02/doctor-hand-hold-offer-patient-medical-marijuana-oil-1-2-scaled.jpg https://els-solutions.com/pt-pt/fda-propoe-nova-etiqueta-nutricional-2/ 2025-02-06T15:40:53+00:00 https://els-solutions.com/cms/wp-content/uploads/2025/02/medium-shot-woman-writing-1-scaled.jpg https://els-solutions.com/fda-propoe-nova-etiqueta-nutricional-2/ 2025-02-06T15:40:53+00:00 https://els-solutions.com/cms/wp-content/uploads/2025/02/medium-shot-woman-writing-1-scaled.jpg https://els-solutions.com/en/fda-proposes-new-nutrition-label-for-healthier-choices-2/ 2025-02-06T15:42:11+00:00 https://els-solutions.com/cms/wp-content/uploads/2025/02/medium-shot-woman-writing-1-scaled.jpg https://els-solutions.com/pt-pt/anvisa-atualiza-procedimentos-para-enquadramento-de-produtos-fronteira-mais-eficiencia-e-acesso-a-inovacoes-no-setor-de-saude/ 2025-02-06T15:52:11+00:00 https://els-solutions.com/cms/wp-content/uploads/2025/02/doctor-hand-hold-offer-patient-medical-marijuana-oil-1-2-scaled.jpg https://els-solutions.com/en/apmc-conducts-innovative-study-on-medicinal-cannabis-2/ 2025-02-06T15:56:22+00:00 https://els-solutions.com/cms/wp-content/uploads/2025/02/doctor-hand-hold-offer-patient-medical-marijuana-oil-1-2-scaled.jpg https://els-solutions.com/en/anvisa-implements-changes-to-drug-registration/ 2025-02-13T09:51:38+00:00 https://els-solutions.com/cms/wp-content/uploads/2025/01/pills-pills-pills-3-1326912-1-scaled.jpg https://els-solutions.com/pt-pt/conheca-a-nova-plataforma-europeia-dedicada-aos-medicamentos/ 2025-02-17T10:51:59+00:00 https://els-solutions.com/cms/wp-content/uploads/2025/02/flat-lay-white-pills-arrangement-2-scaled.jpg https://els-solutions.com/conheca-a-nova-plataforma-europeia-dedicada-aos-medicamentos/ 2025-02-17T10:51:59+00:00 https://els-solutions.com/cms/wp-content/uploads/2025/02/flat-lay-white-pills-arrangement-2-scaled.jpg https://els-solutions.com/en/esmp-enhancing-medicine-shortage-management-in-the-eu/ 2025-02-17T10:52:32+00:00 https://els-solutions.com/cms/wp-content/uploads/2025/02/flat-lay-white-pills-arrangement-2-scaled.jpg https://els-solutions.com/pt-pt/anvisa-atualiza-lista-de-medicamentos-de-referencia/ 2025-02-19T09:41:45+00:00 https://els-solutions.com/cms/wp-content/uploads/2025/02/Groups-of-the-Reference-List-of-Medicines.png https://els-solutions.com/anvisa-atualiza-lista-de-medicamentos-de-referencia/ 2025-02-19T09:41:45+00:00 https://els-solutions.com/cms/wp-content/uploads/2025/02/Groups-of-the-Reference-List-of-Medicines.png https://els-solutions.com/en/sammed-opens-for-2024-h2-marketing-report-submission/ 2025-02-19T10:10:55+00:00 https://els-solutions.com/cms/wp-content/uploads/2025/02/Medicines-Marketing-Report.png https://els-solutions.com/sammed-abre-envio-do-relatorio-de-comercializacao/ 2025-02-19T10:10:55+00:00 https://els-solutions.com/cms/wp-content/uploads/2025/02/Medicines-Marketing-Report.png https://els-solutions.com/rdc-no-947-anvisa-digitaliza-100-dos-processos-de-protocolo/ 2025-02-19T12:30:59+00:00 https://els-solutions.com/cms/wp-content/uploads/2025/02/christin-hume-Hcfwew744z4-unsplash-1-scaled.jpg https://els-solutions.com/en/rdc-no-947-anvisa-shifts-to-100-digital-protocol-processes/ 2025-02-19T12:31:24+00:00 https://els-solutions.com/cms/wp-content/uploads/2025/02/christin-hume-Hcfwew744z4-unsplash-1-scaled.jpg https://els-solutions.com/infarmed-anuncia-novo-regulamento-de-medicamentos/ 2025-02-20T15:20:15+00:00 https://els-solutions.com/cms/wp-content/uploads/2025/02/volodymyr-hryshchenko-m1Hq4ibP9rc-unsplash-1-scaled.jpg https://els-solutions.com/pt-pt/infarmed-anuncia-novo-regulamento-de-medicamentos/ 2025-02-20T15:26:18+00:00 https://els-solutions.com/cms/wp-content/uploads/2025/02/volodymyr-hryshchenko-m1Hq4ibP9rc-unsplash-1-scaled.jpg https://els-solutions.com/pt-pt/rdc-no-947-anvisa-digitaliza-100-dos-processos-de-protocolo/ 2025-02-20T15:27:27+00:00 https://els-solutions.com/cms/wp-content/uploads/2025/02/christin-hume-Hcfwew744z4-unsplash-1-scaled.jpg https://els-solutions.com/pt-pt/sammed-abre-envio-do-relatorio-de-comercializacao/ 2025-02-20T15:28:19+00:00 https://els-solutions.com/cms/wp-content/uploads/2025/02/Medicines-Marketing-Report.png https://els-solutions.com/en/infarmeds-new-medicine-availability-regulation-in-portugal/ 2025-02-21T16:18:43+00:00 https://els-solutions.com/cms/wp-content/uploads/2025/02/volodymyr-hryshchenko-m1Hq4ibP9rc-unsplash-1-scaled.jpg https://els-solutions.com/en/pgeu-has-published-the-2024-medicine-shortagess-annual-report-2/ 2025-02-24T10:54:01+00:00 https://els-solutions.com/cms/wp-content/uploads/2025/02/Escassez-de-Medicamento.png https://els-solutions.com/pgeu-publica-relatorio-anual-sobre-a-escassez-de-medicamentos/ 2025-02-24T11:11:32+00:00 https://els-solutions.com/cms/wp-content/uploads/2025/02/Escassez-de-Medicamento.png https://els-solutions.com/en/pgeu-has-published-the-2024-medicine-shortagess-annual-report/ 2025-02-24T11:12:17+00:00 https://els-solutions.com/cms/wp-content/uploads/2025/02/Escassez-de-Medicamento.png https://els-solutions.com/pt-pt/pgeu-publica-relatorio-anual-sobre-a-escassez-de-medicamentos/ 2025-02-24T11:27:59+00:00 https://els-solutions.com/cms/wp-content/uploads/2025/02/Escassez-de-Medicamento.png https://els-solutions.com/pt-pt/ema-implementa-aconselhamento-para-dispositivos-medicos/ 2025-02-24T11:59:56+00:00 https://els-solutions.com/cms/wp-content/uploads/2025/02/High-Risk-Medical-Devices.png https://els-solutions.com/ema-implementa-aconselhamento-para-dispositivos-medicos/ 2025-02-24T11:59:56+00:00 https://els-solutions.com/cms/wp-content/uploads/2025/02/High-Risk-Medical-Devices.png https://els-solutions.com/en/new-standard-procedure-advice-for-high-risk-medical-devices/ 2025-02-24T12:00:26+00:00 https://els-solutions.com/cms/wp-content/uploads/2025/02/High-Risk-Medical-Devices.png https://els-solutions.com/en/anvisa-updates-the-reference-medicines-list/ 2025-02-26T11:15:41+00:00 https://els-solutions.com/cms/wp-content/uploads/2025/02/Groups-of-the-Reference-List-of-Medicines.png https://els-solutions.com/novas-regras-de-exportacao-de-medicamentos-em-portugal-mudancas-de-2025/ 2025-02-28T14:00:44+00:00 https://els-solutions.com/cms/wp-content/uploads/2025/02/ruchindra-gunasekara-GK8x_XCcDZg-unsplash-1-scaled-e1740760874182.jpg https://els-solutions.com/pt-pt/novas-regras-de-exportacao-de-medicamentos-em-portugal-mudancas-de-2025/ 2025-02-28T17:02:20+00:00 https://els-solutions.com/cms/wp-content/uploads/2025/02/ruchindra-gunasekara-GK8x_XCcDZg-unsplash-1-scaled-e1740760874182.jpg https://els-solutions.com/en/new-rules-for-medicine-export-control-in-portugal-2/ 2025-02-28T17:05:04+00:00 https://els-solutions.com/cms/wp-content/uploads/2025/02/ruchindra-gunasekara-GK8x_XCcDZg-unsplash-1-scaled-e1740760874182.jpg https://els-solutions.com/els-group-organiza-webinar-sobre-cannabis-na-europa/ 2025-03-03T17:04:26+00:00 https://els-solutions.com/cms/wp-content/uploads/2025/03/Marco-Youtube-1.png https://els-solutions.com/pt-pt/els-group-organiza-webinar-sobre-cannabis-na-europa/ 2025-03-03T17:04:26+00:00 https://els-solutions.com/cms/wp-content/uploads/2025/03/Marco-Youtube-1.png https://els-solutions.com/exportacoes-da-saude-em-portugal-crescem-216-em-2024/ 2025-03-09T22:21:49+00:00 https://els-solutions.com/cms/wp-content/uploads/2025/03/Exportacoes-em-Saude.png https://els-solutions.com/pt-pt/exportacoes-da-saude-em-portugal-crescem-216-em-2024/ 2025-03-09T22:21:49+00:00 https://els-solutions.com/cms/wp-content/uploads/2025/03/Exportacoes-em-Saude.png https://els-solutions.com/en/portugals-health-exports-grow-21-6-in-2024/ 2025-03-09T22:22:32+00:00 https://els-solutions.com/cms/wp-content/uploads/2025/03/Exportacoes-em-Saude.png https://els-solutions.com/estudos-degradacao-forcada-medicamentos-2/ 2025-03-09T22:37:09+00:00 https://els-solutions.com/cms/wp-content/uploads/2025/03/Estudos-de-Degradacao-Forcada-em-medicamentos-.png https://els-solutions.com/pt-pt/estudos-degradacao-forcada-medicamentos-2/ 2025-03-09T22:37:09+00:00 https://els-solutions.com/cms/wp-content/uploads/2025/03/Estudos-de-Degradacao-Forcada-em-medicamentos-.png https://els-solutions.com/en/resolution-no-964-2025-forced-degradation-studies/ 2025-03-09T22:37:36+00:00 https://els-solutions.com/cms/wp-content/uploads/2025/03/Estudos-de-Degradacao-Forcada-em-medicamentos-.png https://els-solutions.com/en/els-group-hosts-webinar-on-cannabis-in-europe/ 2025-03-11T10:44:23+00:00 https://els-solutions.com/cms/wp-content/uploads/2025/03/Marco-Youtube-1.png https://els-solutions.com/pt-pt/atualizacao-notificacao-previa-exportacao-medicamentos-2025/ 2025-03-19T18:14:46+00:00 https://els-solutions.com/cms/wp-content/uploads/2025/03/Exportacao-medicamentos-.png https://els-solutions.com/atualizacao-notificacao-previa-exportacao-medicamentos-2025/ 2025-03-19T18:14:46+00:00 https://els-solutions.com/cms/wp-content/uploads/2025/03/Exportacao-medicamentos-.png https://els-solutions.com/en/atualizacao-notificacao-previa-exportacao-medicamentos-2025/ 2025-03-19T18:27:44+00:00 https://els-solutions.com/cms/wp-content/uploads/2025/03/Exportacao-medicamentos-.png https://els-solutions.com/pt-pt/lei-de-medicamentos-criticos/ 2025-03-21T10:17:48+00:00 https://els-solutions.com/cms/wp-content/uploads/2025/03/Critical-Medicines-Act-1.png https://els-solutions.com/lei-de-medicamentos-criticos/ 2025-03-21T10:17:48+00:00 https://els-solutions.com/cms/wp-content/uploads/2025/03/Critical-Medicines-Act-1.png https://els-solutions.com/pt-pt/regulacao-de-medicamentos-na-uniao-europeia-ate-2028/ 2025-03-21T10:18:04+00:00 https://els-solutions.com/cms/wp-content/uploads/2025/03/Medicines-Regulation-in-the-European-Union-.png https://els-solutions.com/regulacao-de-medicamentos-na-uniao-europeia-ate-2028/ 2025-03-21T10:18:04+00:00 https://els-solutions.com/cms/wp-content/uploads/2025/03/Medicines-Regulation-in-the-European-Union-.png https://els-solutions.com/en/critical-medicines-act/ 2025-03-21T10:20:33+00:00 https://els-solutions.com/cms/wp-content/uploads/2025/03/Critical-Medicines-Act-1.png https://els-solutions.com/en/strategy-for-medicines-regulation-in-the-european-union/ 2025-03-21T10:21:02+00:00 https://els-solutions.com/cms/wp-content/uploads/2025/03/Medicines-Regulation-in-the-European-Union-.png https://els-solutions.com/pt-pt/els-group-e-finalista-do-premio-sindusfarma-de-qualidade-2025/ 2025-03-22T10:37:58+00:00 https://els-solutions.com/cms/wp-content/uploads/2025/03/Design-sem-nome-3.png https://els-solutions.com/els-group-e-finalista-do-premio-sindusfarma-de-qualidade-2025/ 2025-03-22T10:37:58+00:00 https://els-solutions.com/cms/wp-content/uploads/2025/03/Design-sem-nome-3.png https://els-solutions.com/en/els-group-named-finalist-for-the-2025-sindusfarma-quality-award-in-two-categories/ 2025-03-22T10:38:30+00:00 https://els-solutions.com/cms/wp-content/uploads/2025/03/Design-sem-nome-3.png https://els-solutions.com/dados-monitoramento-precos-dispositivos-medicos/ 2025-03-24T23:19:55+00:00 https://els-solutions.com/cms/wp-content/uploads/2025/03/Medical-Device-Price-Monitoring-Data.png https://els-solutions.com/pt-pt/novas-regras-produtos-cosmeticos-portugal/ 2025-03-25T15:23:19+00:00 https://els-solutions.com/cms/wp-content/uploads/2025/03/Cosmetic-Products-in-Portugal.png https://els-solutions.com/novas-regras-produtos-cosmeticos-portugal/ 2025-03-25T15:23:19+00:00 https://els-solutions.com/cms/wp-content/uploads/2025/03/Cosmetic-Products-in-Portugal.png https://els-solutions.com/pt-pt/dados-monitoramento-precos-dispositivos-medicos/ 2025-03-25T15:25:12+00:00 https://els-solutions.com/cms/wp-content/uploads/2025/03/Medical-Device-Price-Monitoring-Data.png https://els-solutions.com/en/cosmetic-products-in-portugal/ 2025-03-25T15:40:43+00:00 https://els-solutions.com/cms/wp-content/uploads/2025/03/Cosmetic-Products-in-Portugal.png https://els-solutions.com/en/medical-device-price-monitoring-data/ 2025-03-25T15:41:33+00:00 https://els-solutions.com/cms/wp-content/uploads/2025/03/Medical-Device-Price-Monitoring-Data.png https://els-solutions.com/produtos-base-cannabis-fins-medicinais-brasil/ 2025-04-28T10:19:30+00:00 https://els-solutions.com/cms/wp-content/uploads/2025/04/richard-t-yovhXPl8V1M-unsplash-2-min-scaled.jpg https://els-solutions.com/en/good-manufacturing-practices-for-medicines/ 2025-04-28T10:23:26+00:00 https://els-solutions.com/cms/wp-content/uploads/2025/04/Imagem-Noticias-Website-2.png https://els-solutions.com/pt-pt/boas-praticas-fabricacao-medicamentos/ 2025-04-28T10:23:26+00:00 https://els-solutions.com/cms/wp-content/uploads/2025/04/Imagem-Noticias-Website-2.png https://els-solutions.com/boas-praticas-fabricacao-medicamentos/ 2025-04-28T10:23:26+00:00 https://els-solutions.com/cms/wp-content/uploads/2025/04/Imagem-Noticias-Website-2.png https://els-solutions.com/pt-pt/regras-produtos-cannabis-uso-medicinal-brasil/ 2025-04-28T10:24:08+00:00 https://els-solutions.com/cms/wp-content/uploads/2025/04/Imagem-Noticias-Website-1.png https://els-solutions.com/regras-produtos-cannabis-uso-medicinal-brasil/ 2025-04-28T10:24:08+00:00 https://els-solutions.com/cms/wp-content/uploads/2025/04/Imagem-Noticias-Website-1.png https://els-solutions.com/en/rules-cannabis-products-medicina-use-in-brazil/ 2025-04-28T10:24:32+00:00 https://els-solutions.com/cms/wp-content/uploads/2025/04/Imagem-Noticias-Website-1.png https://els-solutions.com/en/cannabis-based-products-medicinal-purposes-in-brazil/ 2025-04-28T10:28:40+00:00 https://els-solutions.com/cms/wp-content/uploads/2025/04/richard-t-yovhXPl8V1M-unsplash-2-min-scaled.jpg https://els-solutions.com/pt-pt/produtos-base-cannabis-fins-medicinais-brasil/ 2025-04-28T10:53:14+00:00 https://els-solutions.com/cms/wp-content/uploads/2025/04/richard-t-yovhXPl8V1M-unsplash-2-min-scaled.jpg https://els-solutions.com/pt-pt/anvisa-marco-regulatorio-dispositivos-medicos/ 2025-05-12T16:47:54+00:00 https://els-solutions.com/cms/wp-content/uploads/2025/05/Imagem-Noticias-Website-5.png https://els-solutions.com/anvisa-marco-regulatorio-dispositivos-medicos/ 2025-05-12T16:47:54+00:00 https://els-solutions.com/cms/wp-content/uploads/2025/05/Imagem-Noticias-Website-5.png https://els-solutions.com/en/anvisa-new-regulatory-framework-medical-devices/ 2025-05-12T16:49:12+00:00 https://els-solutions.com/cms/wp-content/uploads/2025/05/Imagem-Noticias-Website-5.png https://els-solutions.com/pt-pt/infarmed-atualizou-lista-medicamentos-exportacao-temporariamente-proibida/ 2025-05-13T11:38:20+00:00 https://els-solutions.com/cms/wp-content/uploads/2025/05/Imagem-Noticias-Website-6.png https://els-solutions.com/infarmed-atualizou-lista-medicamentos-exportacao-temporariamente-proibida/ 2025-05-13T11:38:20+00:00 https://els-solutions.com/cms/wp-content/uploads/2025/05/Imagem-Noticias-Website-6.png https://els-solutions.com/en/exports-medicines-temporarily-suspended-ensure-national-supply/ 2025-05-13T11:39:20+00:00 https://els-solutions.com/cms/wp-content/uploads/2025/05/Imagem-Noticias-Website-6.png https://els-solutions.com/pt-pt/evento-ciberseguranca-conformidade-regulatoria-area-saude/ 2025-05-20T17:08:32+00:00 https://els-solutions.com/cms/wp-content/uploads/2025/05/Cybersecurity-and-Regulatory-Compliance-in-Healthcare.png https://els-solutions.com/evento-ciberseguranca-conformidade-regulatoria-area-saude/ 2025-05-20T17:08:32+00:00 https://els-solutions.com/cms/wp-content/uploads/2025/05/Cybersecurity-and-Regulatory-Compliance-in-Healthcare.png https://els-solutions.com/novo-marco-historico-regulatorio-no-brasil-anvisa-publica-rdc-cannabis-medicinal/ 2026-02-05T13:00:36+00:00 https://els-solutions.com/cms/wp-content/uploads/2026/02/medical-devices-38.png https://els-solutions.com/pt-pt/novo-marco-historico-regulatorio-no-brasil-anvisa-publica-rdc-cannabis-medicinal/ 2026-02-06T13:33:53+00:00 https://els-solutions.com/cms/wp-content/uploads/2026/02/medical-devices-38.png https://els-solutions.com/en/new-historical-and-regulatory-milestone-in-brazil-anvisa-publishes-rdcs-on-medicinal-cannabis/ 2026-02-06T20:40:49+00:00 https://els-solutions.com/cms/wp-content/uploads/2026/02/medical-devices-38.png